Table of Contents
Molecular Biology International
Volume 2012 (2012), Article ID 797342, 9 pages
http://dx.doi.org/10.1155/2012/797342
Research Article

Prevention of Lysosomal Storage Diseases and Derivation of Mutant Stem Cell Lines by Preimplantation Genetic Diagnosis

1“ZOHAR” PGD Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center, P.O. Box 3235, Jerusalem 91031, Israel
2School of Medicine, The Hebrew University, Jerusalem, Israel
3Stem Cell Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center, P.O. Box 3235, Jerusalem 91031, Israel
4IVF Unit, Shaare Zedek Medical Center, P.O. Box 3235, Jerusalem 91031, Israel
5Gaucher Clinic, Shaare Zedek Medical Center, P.O. Box 3235, Jerusalem 91031, Israel

Received 13 June 2012; Accepted 27 November 2012

Academic Editor: Mouldy Sioud

Copyright © 2012 Gheona Altarescu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. Handyside, E. H. Kontogianni, K. Hardy, and R. M. L. Winston, “Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification,” Nature, vol. 344, no. 6268, pp. 768–770, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Goossens, J. Traeger-Synodinos, E. Coonen et al., “ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009,” Human Reproduction, vol. 27, no. 7, pp. 1887–1911, 2010. View at Google Scholar
  3. G. Altarescu, B. Brooks, E. Margalioth, T. E. Geva, E. Levy-Lahad, and P. Renbaum, “Simultaneous preimplantation genetic diagnosis for Tay-Sachs and Gaucher disease,” Reproductive BioMedicine Online, vol. 15, no. 1, pp. 83–88, 2007. View at Google Scholar · View at Scopus
  4. T. M. Alberola, R. Bautista-Llácer, E. Fernández, X. Vendrell, and M. Pérez-Alonso, “Preimplantation genetic diagnosis of P450 oxidoreductase deficiency and Huntington Disease using three different molecular approaches simultaneously,” Journal of Assisted Reproduction and Genetics, vol. 26, no. 5, pp. 263–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Rechitsky, M. Freidine, Y. Verlinsky, and C. M. Strom, “Allele dropout in sequential PCR and FISH analysis of single cells (cell recycling),” Journal of Assisted Reproduction and Genetics, vol. 13, no. 2, pp. 115–124, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. A. R. Thornhill, J. A. McGrath, R. A. J. Eady, P. R. Braude, and A. H. Handyside, “A comparison of different lysis buffers to assess allele dropout from single cells for preimplantation genetic diagnosis,” Prenatal Diagnosis, vol. 21, no. 6, pp. 490–497, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Rechitsky, C. Strom, O. Verlinsky, T. Amet, V. Ivakhnenko, and V. Kukharenko, “Allele dropout in polar bodies and blastomeres,” Journal of Assisted Reproduction and Genetics, vol. 15, no. 5, pp. 253–257, 1998. View at Google Scholar
  8. P. Renbaum, B. Brooks, Y. Kaplan et al., “Advantages of multiple markers and polar body analysis in preimplantation genetic diagnosis for Alagille disease,” Prenatal Diagnosis, vol. 27, no. 4, pp. 317–321, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Altarescu, P. Renbaum, B. P. Brooks et al., “Successful polar body-based preimplantation genetic diagnosis for achondroplasia,” Reproductive BioMedicine Online, vol. 16, no. 2, pp. 276–282, 2008. View at Google Scholar · View at Scopus
  10. Y. Verlinsky, J. Cohen, S. Munne et al., “Over a decade of experience with preimplantation genetic diagnosis,” Fertility and Sterility, vol. 82, no. 2, pp. 302–303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Vellodi, “Lysosomal storage disorders,” British Journal of Haematology, vol. 128, no. 4, pp. 413–431, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Bley, O. A. Giannikopoulos, D. Hayden, K. Kubilus, C. J. Tifft, and F. S. Eichler, “Natural history of infantile G(M2) gangliosidosis,” Pediatrics, vol. 128, no. 5, pp. e1233–e1241, 2011. View at Google Scholar
  13. B. L. Triggs-Raine, A. S. J. Feigenbaum, M. Natowicz et al., “Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests,” New England Journal of Medicine, vol. 323, no. 1, pp. 6–12, 1990. View at Google Scholar · View at Scopus
  14. A. Zimran, T. Gelbart, B. Westwood, G. A. Grabowski, and E. Beutler, “High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews,” American Journal of Human Genetics, vol. 49, no. 4, pp. 855–859, 1991. View at Google Scholar · View at Scopus
  15. J. Goldblatt, “Type I Gaucher disease,” Journal of Medical Genetics, vol. 25, no. 6, pp. 415–418, 1988. View at Publisher · View at Google Scholar
  16. P. Le Coutre, A. Demina, E. Beutler, M. Beck, and P. E. Petrides, “Molecular analysis of Gancher disease: distribution of eight mutations and the complete gene deletion in 27 patients from Germany,” Human Genetics, vol. 99, no. 6, pp. 816–821, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Wraith, M. Scarpa, M. Beck et al., “Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy,” European Journal of Pediatrics, vol. 167, no. 3, pp. 267–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. E. Wraith, “Enzyme replacement therapy for the management of the mucopolysaccharidoses,” International Journal of Clinical Pharmacology and Therapeutics, vol. 47, supplement 1, pp. S63–S65, 2009. View at Google Scholar
  19. B. J. H. M. Poorthuis, R. A. Wevers, W. J. Kleijer et al., “The frequency of lysosomal storage diseases in The Netherlands,” Human Genetics, vol. 105, no. 1-2, pp. 151–156, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Jones, Z. Almássy, M. Beck et al., “Mortality and cause of death in mucopolysaccharidosis type II—a historical review based on data from the Hunter Outcome Survey (HOS),” Journal of Inherited Metabolic Disease, vol. 32, no. 4, pp. 534–543, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. O. Brady, “Enzymatic abnormalities in diseases of sphingolipid metabolism,” Clinical Chemistry, vol. 13, no. 7, pp. 565–577, 1967. View at Google Scholar · View at Scopus
  22. K. Toyooka, “Fabry disease,” Current Opinion in Neurology, vol. 24, no. 5, pp. 463–468, 2011. View at Google Scholar
  23. C. M. Eng, L. A. Resnick-Silverman, D. J. Niehaus, K. H. Astrin, and R. J. Desnick, “Nature and frequency of mutations in the α-galactosidase A gene that cause Fabry disease,” American Journal of Human Genetics, vol. 53, no. 6, pp. 1186–1197, 1993. View at Google Scholar · View at Scopus
  24. M. Erdos, K. Németh, B. Tóth, T. Constantin, E. Rákóczi, and A. Ponyi, “Novel sequence variants of the alpha-galactosidase A gene in patients with Fabry disease,” Molecular Genetics and Metabolism, vol. 95, no. 4, pp. 224–228, 2008. View at Google Scholar
  25. I. Verlinsky and A. Kuliev, “Micromanipulation and biopsy of polar bodies and blastomeres,” in Atlas of Preimplantation Genetic Diagnosis, I. K. A. Verlinsky, Ed., pp. 15–22, Taylor and Francis, Abrington, Oxon, UK, 2nd edition, 2005. View at Google Scholar
  26. G. L. Harton, M. De Rycke, F. Fiorentino et al., “ESHRE PGD consortium best practice guidelines for amplification-based PGD,” Human Reproduction, vol. 26, no. 1, pp. 33–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Altarescu, P. Renbaum, T. Eldar-Geva, B. Brooks, I. Varshaver, M. Avitzour et al., “Preventing mucopolysaccharidosis type II (Hunter syndrome): PGD and establishing a Hunter (46, XX) stem cell line,” Prenat Diagn. In press.
  28. P. Kozlowski, A. Knippel, and R. Stressig, “Individual risk of fetal loss following routine second trimester amniocentesis: a controlled study of 20 460 cases,” Ultraschall in der Medizin, vol. 29, no. 2, pp. 165–172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Ribner, G. Altarescu, A. Zimran, and D. Elstein, “Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease,” Movement Disorders, vol. 26, no. 7, pp. 1341–1343, 2011. View at Publisher · View at Google Scholar · View at Scopus